Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1994 Dec;49(12):1259–1266. doi: 10.1136/thx.49.12.1259

Studies using radiolabelled aerosols in children.

M L Everard 1
PMCID: PMC475337  PMID: 7878565

Full text

PDF
1259

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alderson P. O., Secker-Walker R. H., Stominger D. B., Markham J., Hill R. L. Pulmonary deposition of aerosols in children with cystic fibrosis. J Pediatr. 1974 Apr;84(4):479–484. doi: 10.1016/s0022-3476(74)80664-5. [DOI] [PubMed] [Google Scholar]
  2. Alvine G. F., Rodgers P., Fitzsimmons K. M., Ahrens R. C. Disposable jet nebulizers. How reliable are they? Chest. 1992 Feb;101(2):316–319. doi: 10.1378/chest.101.2.316. [DOI] [PubMed] [Google Scholar]
  3. Anderson P. J., Blanchard J. D., Brain J. D., Feldman H. A., McNamara J. J., Heyder J. Effect of cystic fibrosis on inhaled aerosol boluses. Am Rev Respir Dis. 1989 Nov;140(5):1317–1324. doi: 10.1164/ajrccm/140.5.1317. [DOI] [PubMed] [Google Scholar]
  4. Asmundsson T., Johnson R. F., Kilburn K. H., Goodrich J. K. Efficiency of nebulizers for depositing saline in human lung. Am Rev Respir Dis. 1973 Sep;108(3):506–512. doi: 10.1164/arrd.1973.108.3.506. [DOI] [PubMed] [Google Scholar]
  5. Atkins H. L., Weber D. A., Susskind H., Thomas S. R. MIRD dose estimate report no. 16: radiation absorbed dose from technetium-99m-diethylenetriaminepentaacetic acid aerosol. J Nucl Med. 1992 Sep;33(9):1717–1719. [PubMed] [Google Scholar]
  6. Bennett W. D. Aerosolized drug delivery: fractional deposition of inhaled particles. J Aerosol Med. 1991 Fall;4(3):223–227. doi: 10.1089/jam.1991.4.223. [DOI] [PubMed] [Google Scholar]
  7. Bennett W. D., Ilowite J. S. Dual pathway clearance of 99mTc-DTPA from the bronchial mucosa. Am Rev Respir Dis. 1989 May;139(5):1132–1138. doi: 10.1164/ajrccm/139.5.1132. [DOI] [PubMed] [Google Scholar]
  8. Borgström L., Bondesson E., Morén F., Trofast E., Newman S. P. Lung deposition of budesonide inhaled via Turbuhaler: a comparison with terbutaline sulphate in normal subjects. Eur Respir J. 1994 Jan;7(1):69–73. doi: 10.1183/09031936.94.07010069. [DOI] [PubMed] [Google Scholar]
  9. Borgström L., Newman S., Weisz A., Morén F. Pulmonary deposition of inhaled terbutaline: comparison of scanning gamma camera and urinary excretion methods. J Pharm Sci. 1992 Aug;81(8):753–755. doi: 10.1002/jps.2600810807. [DOI] [PubMed] [Google Scholar]
  10. Chan H. K. Use of single photon emission computed tomography in aerosol studies. J Aerosol Med. 1993 Spring;6(1):23–36. doi: 10.1089/jam.1993.6.23. [DOI] [PubMed] [Google Scholar]
  11. Clay M. M., Clarke S. W. Effect of nebulised aerosol size on lung deposition in patients with mild asthma. Thorax. 1987 Mar;42(3):190–194. doi: 10.1136/thx.42.3.190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Collis G. G., Cole C. H., Le Souëf P. N. Dilution of nebulised aerosols by air entrainment in children. Lancet. 1990 Aug 11;336(8711):341–343. doi: 10.1016/0140-6736(90)91880-j. [DOI] [PubMed] [Google Scholar]
  13. Demedts M., De Man F. Circulating immune complexes in chronic eosinophilic pneumonia. Acta Clin Belg. 1991;46(2):75–81. doi: 10.1080/17843286.1991.11718146. [DOI] [PubMed] [Google Scholar]
  14. Everard M. L., Clark A. R., Milner A. D. Drug delivery from holding chambers with attached facemask. Arch Dis Child. 1992 May;67(5):580–585. doi: 10.1136/adc.67.5.580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Everard M. L., Clark A. R., Milner A. D. Drug delivery from jet nebulisers. Arch Dis Child. 1992 May;67(5):586–591. doi: 10.1136/adc.67.5.586. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Everard M. L., Hardy J. G., Milner A. D. Comparison of nebulised aerosol deposition in the lungs of healthy adults following oral and nasal inhalation. Thorax. 1993 Oct;48(10):1045–1046. doi: 10.1136/thx.48.10.1045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Everard M. L., Stammers J., Hardy J. G., Milner A. D. New aerosol delivery system for neonatal ventilator circuits. Arch Dis Child. 1992 Jul;67(7 Spec No):826–830. doi: 10.1136/adc.67.7_spec_no.826. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Forge N. I., Mountford P. J., O'Doherty M. J. Quantification of technetium-99m lung radioactivity from planar images. Eur J Nucl Med. 1993 Jan;20(1):10–15. doi: 10.1007/BF02261239. [DOI] [PubMed] [Google Scholar]
  19. Hindle M., Newton D. A., Chrystyn H. Investigations of an optimal inhaler technique with the use of urinary salbutamol excretion as a measure of relative bioavailability to the lung. Thorax. 1993 Jun;48(6):607–610. doi: 10.1136/thx.48.6.607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Huchon G. J., Montgomery A. B., Lipavsky A., Hoeffel J. M., Murray J. F. Respiratory clearance of aerosolized radioactive solutes of varying molecular weight. J Nucl Med. 1987 May;28(5):894–902. [PubMed] [Google Scholar]
  21. Huda Walter, Scrimger John W. Irradiation of volunteers in nuclear medicine. J Nucl Med Allied Sci. 1989 Feb;30(2):260–264. [PubMed] [Google Scholar]
  22. Köhler D., Fleischer W., Matthys H. New method for easy labeling of beta-2-agonists in the metered dose inhaler with technetium 99m. Respiration. 1988;53(2):65–73. doi: 10.1159/000195399. [DOI] [PubMed] [Google Scholar]
  23. Logus J. W., Trajan M., Hooper H. R., Lentle B. C., Man S. F. Single photon emission tomography of lungs imaged with 99mTc-labeled aerosol. J Can Assoc Radiol. 1984 Jun;35(2):133–138. [PubMed] [Google Scholar]
  24. Lødrup Carlsen K. C., Nikander K., Carlsen K. H. How much nebulised budesonide reaches infants and toddlers? Arch Dis Child. 1992 Sep;67(9):1077–1079. doi: 10.1136/adc.67.9.1077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Macey D. J., Marshall R. Absolute quantitation of radiotracer uptake in the lungs using a gamma camera. J Nucl Med. 1982 Aug;23(8):731–734. [PubMed] [Google Scholar]
  26. Makrigiorgos G. M., Adelstein S. J., Kassis A. I. Limitations of conventional internal dosimetry at the cellular level. J Nucl Med. 1989 Nov;30(11):1856–1864. [PubMed] [Google Scholar]
  27. Marshall L. M., Francis P. W., Khafagi F. A. Aerosol deposition in cystic fibrosis using an aerosol conservation device and a conventional jet nebulizer. J Paediatr Child Health. 1994 Feb;30(1):65–67. doi: 10.1111/j.1440-1754.1994.tb00569.x. [DOI] [PubMed] [Google Scholar]
  28. Matthys H. Nebulizer possibilities and limitations. J Aerosol Med. 1991 Fall;4(3):157–162. doi: 10.1089/jam.1991.4.157. [DOI] [PubMed] [Google Scholar]
  29. Melchor R., Biddiscombe M. F., Mak V. H., Short M. D., Spiro S. G. Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction. Thorax. 1993 May;48(5):506–511. doi: 10.1136/thx.48.5.506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Messina M. S., Smaldone G. C. Evaluation of quantitative aerosol techniques for use in bronchoprovocation studies. J Allergy Clin Immunol. 1985 Feb;75(2):252–257. doi: 10.1016/0091-6749(85)90054-5. [DOI] [PubMed] [Google Scholar]
  31. Mukhopadhyay S., Staddon G. E., Eastman C., Palmer M., Davies E. R., Carswell F. The quantitative distribution of nebulized antibiotic in the lung in cystic fibrosis. Respir Med. 1994 Mar;88(3):203–211. doi: 10.1016/s0954-6111(05)80348-8. [DOI] [PubMed] [Google Scholar]
  32. Murakami G., Igarashi T., Adachi Y., Matsuno M., Adachi Y., Sawai M., Yoshizumi A., Okada T. Measurement of bronchial hyperreactivity in infants and preschool children using a new method. Ann Allergy. 1990 Apr;64(4):383–387. [PubMed] [Google Scholar]
  33. Newman S. P., Clark A. R., Talaee N., Clarke S. W. Pressurised aerosol deposition in the human lung with and without an "open" spacer device. Thorax. 1989 Sep;44(9):706–710. doi: 10.1136/thx.44.9.706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Newman S. P., Clarke S. W. Bronchodilator delivery from Gentlehaler, a new low-velocity pressurized aerosol inhaler. Chest. 1993 May;103(5):1442–1446. doi: 10.1378/chest.103.5.1442. [DOI] [PubMed] [Google Scholar]
  35. Newman S. P., Millar A. B., Lennard-Jones T. R., Morén F., Clarke S. W. Improvement of pressurised aerosol deposition with Nebuhaler spacer device. Thorax. 1984 Dec;39(12):935–941. doi: 10.1136/thx.39.12.935. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Newman S. P., Morén F., Trofast E., Talaee N., Clarke S. W. Deposition and clinical efficacy of terbutaline sulphate from Turbuhaler, a new multi-dose powder inhaler. Eur Respir J. 1989 Mar;2(3):247–252. [PubMed] [Google Scholar]
  37. Newman S. P., Pellow P. G., Clarke S. W. Droplet size distributions of nebulised aerosols for inhalation therapy. Clin Phys Physiol Meas. 1986 May;7(2):139–146. doi: 10.1088/0143-0815/7/2/004. [DOI] [PubMed] [Google Scholar]
  38. O'Doherty M. J., Thomas S. H., Gibb D., Page C. J., Harrington C., Duggan C., Nunan T. O., Bateman N. T. Lung deposition of nebulised pentamidine in children. Thorax. 1993 Mar;48(3):220–226. doi: 10.1136/thx.48.3.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. O'Doherty M. J., Thomas S. H., Page C. J., Blower P. J., Bateman N. T., Nunan T. O. Disposition of nebulized pentamidine measured using the direct radiolabel 123I-iodopentamidine. Nucl Med Commun. 1993 Jan;14(1):8–11. doi: 10.1097/00006231-199301000-00003. [DOI] [PubMed] [Google Scholar]
  40. O'Doherty M. J., Thomas S., Page C., Clark A. R., Mitchell D., Heduan E., Nunan T. O., Bateman N. T. Does 99Tcm human serum albumin alter the characteristics of nebulized pentamidine isethionate? Nucl Med Commun. 1989 Jul;10(7):523–529. doi: 10.1097/00006231-198907000-00013. [DOI] [PubMed] [Google Scholar]
  41. Perring S., Summers Q., Fleming J. S., Nassim M. A., Holgate S. T. A new method of quantification of the pulmonary regional distribution of aerosols using combined CT and SPECT and its application to nedocromil sodium administered by metered dose inhaler. Br J Radiol. 1994 Jan;67(793):46–53. doi: 10.1259/0007-1285-67-793-46. [DOI] [PubMed] [Google Scholar]
  42. Phipps P. R., Gonda I., Bailey D. L., Borham P., Bautovich G., Anderson S. D. Comparisons of planar and tomographic gamma scintigraphy to measure the penetration index of inhaled aerosols. Am Rev Respir Dis. 1989 Jun;139(6):1516–1523. doi: 10.1164/ajrccm/139.6.1516. [DOI] [PubMed] [Google Scholar]
  43. Poston J. W. Application of the effective dose equivalent to nuclear medicine patients. The MIRD Committee. J Nucl Med. 1993 Apr;34(4):714–716. [PubMed] [Google Scholar]
  44. Ruffin R. E., Dolovich M. B., Wolff R. K., Newhouse M. T. The effects of preferential deposition of histamine in the human airway. Am Rev Respir Dis. 1978 Mar;117(3):485–492. doi: 10.1164/arrd.1978.117.3.485. [DOI] [PubMed] [Google Scholar]
  45. Salmon B., Wilson N. M., Silverman M. How much aerosol reaches the lungs of wheezy infants and toddlers? Arch Dis Child. 1990 Apr;65(4):401–403. doi: 10.1136/adc.65.4.401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Schuster D. P. Positron emission tomography: theory and its application to the study of lung disease. Am Rev Respir Dis. 1989 Mar;139(3):818–840. doi: 10.1164/ajrccm/139.3.818. [DOI] [PubMed] [Google Scholar]
  47. Smaldone G. C., Fuhrer J., Steigbigel R. T., McPeck M. Factors determining pulmonary deposition of aerosolized pentamidine in patients with human immunodeficiency virus infection. Am Rev Respir Dis. 1991 Apr;143(4 Pt 1):727–737. doi: 10.1164/ajrccm/143.4_Pt_1.727. [DOI] [PubMed] [Google Scholar]
  48. Smaldone G. C., Fuhrer J., Steigbigel R. T., McPeck M. Factors determining pulmonary deposition of aerosolized pentamidine in patients with human immunodeficiency virus infection. Am Rev Respir Dis. 1991 Apr;143(4 Pt 1):727–737. doi: 10.1164/ajrccm/143.4_Pt_1.727. [DOI] [PubMed] [Google Scholar]
  49. Spiro S. G., Singh C. A., Tolfree S. E., Partridge M. R., Short M. D. Direct labelling of ipratropium bromide aerosol and its deposition pattern in normal subjects and patients with chronic bronchitis. Thorax. 1984 Jun;39(6):432–435. doi: 10.1136/thx.39.6.432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Stahlhofen W., Gebhart J., Heyder J. Experimental determination of the regional deposition of aerosol particles in the human respiratory tract. Am Ind Hyg Assoc J. 1980 Jun;41(6):385–98a. doi: 10.1080/15298668091424933. [DOI] [PubMed] [Google Scholar]
  51. Steventon R. D., Wilson R. S. Facemask or mouthpiece for delivery of nebulized bronchodilator aerosols? Br J Dis Chest. 1981 Jan;75(1):88–90. doi: 10.1016/s0007-0971(81)80012-5. [DOI] [PubMed] [Google Scholar]
  52. Summers Q. A. Inhaled drugs and the lung. Clin Exp Allergy. 1991 May;21(3):259–268. doi: 10.1111/j.1365-2222.1991.tb01657.x. [DOI] [PubMed] [Google Scholar]
  53. Swift D. L. Age-related scaling for aerosol and vapor deposition in the upper airways of humans. Health Phys. 1989;57 (Suppl 1):293–297. doi: 10.1097/00004032-198907001-00038. [DOI] [PubMed] [Google Scholar]
  54. Thomas S. H., Batchelor S., O'Doherty M. J. Therapeutic aerosols in children. BMJ. 1993 Jul 24;307(6898):245–247. doi: 10.1136/bmj.307.6898.245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Thomas S. H., O'Doherty M. J., Graham A., Page C. J., Blower P., Geddes D. M., Nunan T. O. Pulmonary deposition of nebulised amiloride in cystic fibrosis: comparison of two nebulisers. Thorax. 1991 Oct;46(10):717–721. doi: 10.1136/thx.46.10.717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Thomas S. H., O'Doherty M. J., Page C. J., Nunan T. O. Variability in the measurement of nebulized aerosol deposition in man. Clin Sci (Lond) 1991 Dec;81(6):767–775. doi: 10.1042/cs0810767. [DOI] [PubMed] [Google Scholar]
  57. Thorsson L., Newman S. P., Weisz A., Trofast E., Morén F. Nasal distribution of budesonide inhaled via a powder inhaler. Rhinology. 1993 Mar;31(1):7–10. [PubMed] [Google Scholar]
  58. Vidgren M., Paronen P., Vidgren P., Nuutinen J., Vainio P. Effect of the new spacer-device on the deposition of the inhaled metered dose aerosol. Pharmazie. 1990 Dec;45(12):922–924. [PubMed] [Google Scholar]
  59. Wollmer P., Pride N. B., Rhodes C. G., Sanders A., Pike V. W., Palmer A. J., Silvester D. J., Liss R. H. Measurement of pulmonary erythromycin concentration in patients with lobar pneumonia by means of positron tomography. Lancet. 1982 Dec 18;2(8312):1361–1364. doi: 10.1016/s0140-6736(82)91269-7. [DOI] [PubMed] [Google Scholar]
  60. Zainudin B. M., Biddiscombe M., Tolfree S. E., Short M., Spiro S. G. Comparison of bronchodilator responses and deposition patterns of salbutamol inhaled from a pressurised metered dose inhaler, as a dry powder, and as a nebulised solution. Thorax. 1990 Jun;45(6):469–473. doi: 10.1136/thx.45.6.469. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES